Starting next year, citizens aged 56 and 66 will be able to receive pulmonary function tests as part of the National Health Screening Program. In addition, the out-of-pocket expenses for dyslipidemia ...
Pulmonary function tests for the early diagnosis of chronic obstructive pulmonary disease (COPD) will be included in Korea's national health screening program for the first time next year. The ...
The biologics omalizumab, mepolizumab, benralizumab, and dupilumab have similar effectiveness in improving lung function in severe asthma.
Topline data were announced from a phase 3 trial evaluating dexpramipexole as an add-on therapy in patients with eosinophilic asthma.
Increased triglyceride-glucose (TyG) index values are strongly associated with decreased lung function in healthy individuals.
Select your location to view local American Lung Association events and news near you.
The clearance makes Jascayd the first new drug for idiopathic pulmonary fibrosis in over a decade, but one some analysts see as a “modest” advance in care.
The FDA has approved nerandomilast (Jascayd; Boehringer Ingelheim) for the treatment of adults with idiopathic pulmonary fibrosis (IPF). 1 Nerandomilast's approval marks the first for a novel IPF ...
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback